| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 743227 | 2-chloro-1-[4-(4-chloro-1-cyclohexyl-2,5-dioxo-2,5-dihydro-1 H-3-pyrrolylamino)phenylcarboxamido]benzene | 0.0314734733353265 | 0.47334044 |
| NSC 747556 | 6-(4'-Hydroxy-2'-methylphenyl)-2-benzenesulfonamide-4,5-dihydropyridazine-3(2H)-one | 0.0314734733353267 | 0.51089687 |
| NSC 750441 | Null | 0.0314734733353267 | 0.5805577 |
| NSC 752461 | Null | 0.0314734733353267 | 0.49911034 |
| NSC 755423 | Null | 0.0314734733353267 | 0.45632428 |
| NSC 756170 | GSK317315A | 0.0314734733353267 | 0.38116808 |
| NSC 758356 | 2-(1-(4-chlorophenylsulfonyl)-1H-indol-3-yl)-2-oxo-N-(pyridin-4-yl)acetamide | 0.0314734733353267 | 0.59829961 |
| NSC 92915 | ANTINEOPLASTIC-92915 | 0.0314734733353267 | 0.45243077 |
| NSC 752761 | Null | 0.0329129886465387 | -0.12477472 |
| NSC 756483 | SB-742864 | 0.0329129886465387 | 0.43383359 |